NAGENDRAN SUKUMAR sold 8.1% of their position (116.05K shares) of TAYSHA GENE THERAPIES, INC. on the open market
Open‑market sale worth $547.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/27/2026ACC: 0001665124-26-000008
Director
Since Sep 2020
-116.05K
Net shares
Net seller
$547.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
116.05K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−89.13K
Price / share
$4.75
Trade value
$423.38K
% of position
6.2%
1/23/2026
1.43M→1.34M
Common Stock
Direct
Shares
−26.92K
Price / share
$4.61
Trade value
$124.09K
% of position
2.0%
1/26/2026
1.34M→1.32M
Total
Net shares
−116.05K
Net value
-$547.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2026 | S · Sale | −89.13K | $4.75 | $423.38K | 6.2% | 1.43M | 1.34M |
| Common Stock Direct | 1/26/2026 | S · Sale | −26.92K | $4.61 | $124.09K | 2.0% | 1.34M | 1.32M |
| Total | −116.05K | -$547.47K | ||||||
Derivative Transactions0
No derivative transactions reported